EPS8L2 and colorectal cancer: Furthermore, utilizing patient-derived colorectal cancer organoids as a clinically relevant model system, we demonstrated that EPS8L2 overexpression markedly enhanced organoid formation efficiency, reinforcing its functional role in promoting tumorigenic capacity.